Tag
Utah healthcare startup Nolla Health is piloting AI-generated acne prescriptions through its Nolla Derm app, letting users scan their faces so the AI can analyze severity and autonomously issue prescriptions under gradually loosening physician oversight.
Allia is releasing a new Partner API that allows third-party products to integrate with Allia’s provider network to offer care services directly to users.
RonanRx offers personalized GLP-1 treatments with physician oversight and compounding pharmacies, focusing on tailored dosing and support for side effects.
The article explores the rise of hormone therapy for perimenopausal women, driven by tech startups like Midi and changing medical perspectives, highlighting personal experiences and industry shifts.
The FDA is set to discuss reclassifying peptides for compounding, with telehealth companies like Mochi Health and Hims & Hers preparing to cash in on the anticipated regulatory shift, driven by political influence from HHS Secretary RFK Jr. and the GLP-1 boom.
The article explores how turnkey telehealth services enable virtually anyone—from established companies like JustAnswer to influencers—to sell GLP-1 weight loss drugs online, highlighting the rapid expansion of the digital health market and the role of infrastructure providers.
A journalist recounts being scammed by an online telehealth service that charged him for unwanted GLP-1 medications and refused refunds, highlighting a broader pattern of consumer fraud in the growing online weight-loss drug market.